Cargando…

Correction:Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524368/ https://www.ncbi.nlm.nih.gov/pubmed/34663754 http://dx.doi.org/10.1136/openhrt-2020-001465corr1

Ejemplares similares

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Publicado: (2018)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023)

Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Correction: Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
Publicado: (2019)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation
por: Palamaner Subash Shantha, Ghanshyam, et al.
Publicado: (2017)

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
por: López-López, José A, et al.
Publicado: (2017)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado: (2020)

Correction to: Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation
Publicado: (2022)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
por: Seiffge, David J., et al.
Publicado: (2020)

Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
por: Eun, Mi-Yeon, et al.
Publicado: (2021)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
por: Carlisle, Matthew A., et al.
Publicado: (2022)

Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis
por: Reddin, Catriona, et al.
Publicado: (2021)

Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
por: Varona, José Felipe, et al.
Publicado: (2021)

Correction to: Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation
Publicado: (2022)

Lack of Sex Disparity in Oral Anticoagulation in Atrial Fibrillation Patients Presenting with Ischemic Stroke in a Rural Population
por: Koza, Eric, et al.
Publicado: (2021)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Oral Anticoagulant Therapy in Atrial Fibrillation Cancer Patients
por: Cereda, Alberto, et al.
Publicado: (2023)

Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts
por: Xu, Yan, et al.
Publicado: (2018)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2022)

Correction: IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
por: Ziegler, Louise, et al.
Publicado: (2022)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
por: Witte, Klaus K., et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2mqebtsto98oa3678rcdttpv1